This calculation determines the concentration (e.g., 2.5mg/ml or 2500mcg/ml)
The side effect profiles also differ markedly
However, the raw materials used in the compounded forms may differ from those produced for Novo Nordisk and Lilly, said GLP-1 co-inventor Jens Juul Holst, of the University of Copenhagen, adding that care must be taken in drug production lest it cause potentially harmful immune reactions
The similarity between these findings and those of the main SURPASS-CVOT trial highlights the utility of rigorously designed observational studies to compare the effectiveness of different GLP-1 receptor agonist-based therapies, Ostrominski said
The main factors contributing to their growth are increased usage of GLP-1 products, increasing R&D expenditure by government,and well-established biopharmaceutical and pharmaceutical industry in U.S